指南与共识胃肠外科

EAES、SAGES与ESCP快速指南:微创结直肠切除术的肠道准备

EAES, SAGES, and ESCP rapid guideline: bowel preparation for minimally invasive colorectal resection.
指南 / 共识 · Surg Endosc · 2023-10-30

该快速指南由EAES、SAGES与ESCP联合制定,通过更新系统评价、网络Meta分析及GRADE/CINeMA方法评估证据,由多学科小组就微创结直肠手术前肠道准备形成推荐。推荐根据手术部位和吻合方式选择口服抗生素、机械性肠道准备(MBP)联合口服抗生素或加用灌肠,并给出条件推荐与强推荐。

要点

  • 微创右半结肠切除术前可单独口服抗生素或MBP联合口服抗生素(条件推荐)。
  • 微创左半结肠及乙状结肠切除术前建议MBP联合口服抗生素(条件推荐)。
  • 微创直肠手术前建议MBP联合口服抗生素加灌肠(条件推荐)。

核心结论

  • 该指南针对不同微创结直肠手术方式,提供了肠道准备的循证推荐。
  • 指南 registration number 为 PREPARE-2023CN045。

研究设计与样本

  • EAES、SAGES与ESCP协作项目,更新既往系统评价并开展干预措施的网络Meta分析。
  • 采用GRADE和CINeMA方法评估每个比较的证据确定性。
  • 由普外科与结直肠外科医生、感染病专家、麻醉医生及患者代表组成的小组,在GIN认证的指南方法学专家主持下讨论证据并形成推荐。
  • 推荐经共识会议制定,随后进行改良Delphi调查。

主要发现

  • 小组建议微创右半结肠切除术前单独口服抗生素或MBP联合口服抗生素(条件推荐)。
  • 小组建议微创左半结肠和乙状结肠切除术前,以及计划行体内吻合的微创右半结肠切除术前,使用MBP联合口服抗生素(条件推荐)。
  • 小组建议微创直肠手术前使用MBP联合口服抗生素加灌肠(条件推荐)。
  • 当计划术中定位病灶时,推荐微创结直肠手术前使用MBP联合口服抗生素(强推荐)。

关键数值与推荐

  • 微创右半结肠切除术:单独口服抗生素或MBP联合口服抗生素(条件推荐)。
  • 微创左半结肠和乙状结肠切除术:MBP联合口服抗生素(条件推荐)。
  • 计划行体内吻合的微创右半结肠切除术:MBP联合口服抗生素(条件推荐)。
  • 微创直肠手术:MBP联合口服抗生素加灌肠(条件推荐)。
  • 计划术中定位病灶的微创结直肠手术:MBP联合口服抗生素(强推荐)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Variation exists in practice pertaining to bowel preparation before minimally invasive colorectal surgery. A survey of EAES members prioritized this topic to be addressed by a clinical practice guideline. OBJECTIVE: The aim of the study was to develop evidence-informed clinical practice recommendations on the use of bowel preparation before minimally invasive colorectal surgery, through evidence synthesis and a structured evidence-to-decision framework by an interdisciplinary panel of stakeholders. METHODS: This is a collaborative project of EAES, SAGES, and ESCP. We updated a previous systematic review and performed a network meta-analysis of interventions. We appraised the certainty of the evidence for each comparison, using the GRADE and CINeMA methods. A panel of general and colorectal surgeons, infectious diseases specialists, an anesthetist, and a patient representative discussed the evidence in the context of benefits and harms, the certainty of the evidence, acceptability, feasibility, equity, cost, and use of resources, moderated by a GIN-certified master guideline developer and chair. We developed the recommendations in a consensus meeting, followed by a modified Delphi survey. RESULTS: The panel suggests either oral antibiotics alone prior to minimally invasive right colon resection or mechanical bowel preparation (MBP) plus oral antibiotics; MBP plus oral antibiotics prior to minimally invasive left colon and sigmoid resection, and prior to minimally invasive right colon resection when there is an intention to perform intracorporeal anastomosis; and MBP plus oral antibiotics plus enema prior to minimally invasive rectal surgery (conditional recommendations); and recommends MBP plus oral antibiotics prior to minimally invasive colorectal surgery, when there is an intention to localize the lesion intraoperatively (strong recommendation). The full guideline with user-friendly decision aids is available in https://app.magicapp.org/#/guideline/LwvKej . CONCLUSION: This guideline provides recommendations on bowel preparation prior to minimally invasive colorectal surgery for different procedures, using highest methodological standards, through a structured framework informed by key stakeholders. Guideline registration number PREPARE-2023CN045.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Antoniou SA, Huo B, Tzanis AA, et al. EAES, SAGES, and ESCP rapid guideline: bowel preparation for minimally invasive colorectal resection. Surg Endosc. 2023. PMID: 37903883. doi:10.1007/s00464-023-10477-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。